Sudha Khinchi/ AJPRD
2320-4850
Bi-Monthly
2013
9460235942
YES
India
English
YES
Google Scholar
editorajprd@gmail.com
Asian Journal of Pharmaceutical Research and Development (AJPRD) is an international, peer-reviewed, multidisciplinary online open access journal published bimonthly dedicated to the rapid publication of full-length original research papers, short communications, invited reviews, Case studies and editorial commentary and news, Opinions & Perspectives and Book Reviews written at the invitation of the Editor in all areas of the Pharmaceutical, Medical, Chemistry and Biological Sciences.
There are many types of natural fiber including hemp, flax, jute, wood fiber, rice husks, straw wheat, oats, bagasse, barley, grass reeds, banana fiber, oil palm empty fruit bunch, coir, sis...
OJSCloud offers a complete, free setup to get you publishing.
Start Your Free Journal!Scholar9.com is a peer-review platform that hosts journals from across the globe. Please note that we do not own any of the journals hosted on the platform.
Our platform enables journal owners to send articles for peer review to users who have registered via https://scholar9.com/register and have consented to serve as reviewers for multiple journals. Additionally, we offer an indirect manuscript submission system for journals that are claimed and actively managed by their respective owners on Scholar9.com.
For accurate information about the indexing status of journals (in databases such as UGC CARE, Scopus, or Web of Science) and contact details, users must refer to the respective official websites.
Scholar9 is not responsible for indexing claims, manuscript acceptance/rejection, refunds of article processing charges, or any stage of the final publication process. Users are strongly advised to verify all information provided on the platform independently.
Scholar9.com disclaims liability for disputes related to indexing claims, publication decisions, or other journal-specific matters. Users are encouraged to contact the respective journal owners directly for detailed information and clarifications.